Amyotrophic lateral sclerosis: From disease mechanisms to therapies

BioTechniques

Volumn 32, Issue 5, 2002, Pages 1112-1121

  Bruijn, Lucie I ^a  

^a Innovation Park   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALBINDIN; CATALASE; CHELATING AGENT; COPPER; CREATINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INDOMETACIN; OSTEOGENIC PROTEIN 1; PENICILLAMINE; RILUZOLE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG EFFICACY; ECOTOXICITY; HUMAN; MEDICAL RESEARCH; NITRATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; TREATMENT OUTCOME;

ANIMALIA;

EID: 0036249631     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/02325dd01     Document Type: Article

References (67)

1. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
2. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases
3. Neurogenesis and plasticity in the CNS of adult birds
4. Neurogenesis in adult subventricular zone
5. Can stem cells cross lineage boundaries?
6. Transgenic models of Huntington's disease
7. Mitochondrial dysfunction in neurodegenerative diseases
8. Mitochondria and the pathogenesis of ALS
9. ALS, SOD and peroxynitrite
10. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity
11. From marrow to brain: Expression of neuronal phenotypes in adult mice
12. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
13. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
14. Mechanisms of selective motor neuron death in ALS: Insights from transgenic mouse models of motor neuron disease
15. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
16. Generalized potential of adult neural stem cells
17. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
18. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
19. Gene therapy in the CNS
20. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
21. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
22. A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
23. Inhibition of ICE slows ALS in mice
24. Neurogenesis in the adult brain
25. Stem cell plasticity in muscle and bone marrow
26. Transgenic-mouse model of amyotrophic lateral sclerosis
27. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis
28. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
29. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
30. Mutant Cu, Zn superoxide dismutase that causes motor neuron degeneration is present in mitochondria in the CNS
31. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis
32. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis
33. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus
34. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis
35. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
36. Transgenic mice expressing Alzheimer amyloid precursor proteins
37. Novel drug development for amyotrophic lateral sclerosis
38. Formation of high molecular weight complexes of mutant Cu, Zn- superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
39. Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded
40. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
41. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
42. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
43. Manipulation of neural precursors in situ: Induction of neurogenesis in the neocortex of adult mice
44. Clinical trials of riluzole in patients with ALS
45. Controlled trial of nimodipine in amyotrophic lateral sclerosis
46. A clinical trial of verapamil in amyotrophic lateral sclerosis
47. Familial adult motor neuron disease: Amyotrophic lateral sclerosis
48. Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions
49. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
50. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis
51. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
52. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis
53. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
54. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
55. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis
56. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
57. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease
58. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease
59. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
60. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading
61. High molecular weight complexes of mutant superoxide dismutase 1: Age-dependent and tissue-specific accumulation
62. Adenoviral gene transfer of glial cell line-derived neurotrophic factor to injured adult motoneurons
63. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
64. In vivo gene electroporation of glial cell line-derived neurotrophic factor (GDNF) into skeletal muscle of SOD1 mutant mice
65. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis
66. Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy
67. Oxidative stress and genetics in the pathogenesis of Parkinson's disease